Cardlytics Inc
For the period ended Jun 30, 2024. Filed Aug 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 7, 2024
CDLX$1.63-10.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders' Equity (Unaudited)
Six Months Ended June 30, 2024:
| AdditionalPaid-InCapital · AccumulatedOtherComprehensive Income · AccumulatedDeficit · Total | ||||||
|---|---|---|---|---|---|---|
| Common Stock | ||||||
| Shares · Amount | ||||||
| Balance – December 31, 2023 | 39,728 | $9 | $1,243,594 | $2,467 | $(1,111,272) | $134,798 |
| Exercise of common stock options | 3 | — | 5 | — | — | 5 |
| Stock-based compensation | — | — | 26,099 | — | — | 26,099 |
| Settlement of restricted stock | 1,929 | — | — | — | — | — |
| Issuance of common stock, net of issuance costs - Settlement Agreement (as defined below) | 3,592 | — | 27,451 | — | — | 27,451 |
| Issuance of common stock, net of issuance costs - ATM Offering Program (as defined below) | 3,908 | — | 48,151 | — | — | 48,151 |
| Issuance of common stock pursuant to the 2018 ESPP (as defined below) | 242 | — | 1,461 | — | — | 1,461 |
| Termination of capped calls related to 2020 Convertible Senior Notes | — | — | 115 | — | — | 115 |
| Other comprehensive loss | — | — | — | 486 | — | 486 |
| Net Loss | — | — | — | — | (28,532) | (28,532) |
| Balance – June 30, 2024 | 49,402 | $9 | $1,346,876 | $2,953 | $(1,139,804) | $210,034 |
Three Months Ended June 30, 2024:
| AdditionalPaid-InCapital · AccumulatedOtherComprehensive Income · AccumulatedDeficit · Total | ||||||
|---|---|---|---|---|---|---|
| Common Stock | ||||||
| Shares · Amount | ||||||
| Balance – March 31, 2024 | 48,174 | $9 | $1,331,628 | $3,047 | $(1,135,547) | $199,137 |
| Exercise of common stock options | — | — | — | — | — | — |
| Stock-based compensation | — | — | 13,843 | — | — | 13,843 |
| Settlement of restricted stock | 986 | — | — | — | — | — |
| Issuance of common stock, net of issuance costs | — | — | — | — | — | — |
| Issuance of common stock, net of issuance costs - ATM Offering Program (as defined below) | — | — | (171) | — | — | (171) |
| Issuance of common stock pursuant to the 2018 ESPP (as defined below) | 242 | — | 1,461 | — | — | 1,461 |
| Termination of capped calls related to 2020 Convertible Senior Notes | — | — | 115 | — | — | 115 |
| Other comprehensive loss | — | — | — | (94) | — | (94) |
| Net Loss | — | — | — | — | (4,257) | (4,257) |
| Balance – June 30, 2024 | 49,402 | $9 | $1,346,876 | $2,953 | $(1,139,804) | $210,034 |
Six Months Ended June 30, 2023:
| AdditionalPaid-InCapital · AccumulatedOtherComprehensiveIncome · AccumulatedDeficit · Total | ||||||
|---|---|---|---|---|---|---|
| Common Stock | ||||||
| Shares · Amount | ||||||
| Balance – December 31, 2022 | 33,477 | $9 | $1,182,568 | $5,598 | $(976,570) | $211,605 |
| Exercise of common stock options | 4 | — | 11 | — | — | 11 |
| Stock-based compensation | — | — | 20,676 | — | — | 20,676 |
| Settlement of restricted stock | 570 | — | — | — | — | — |
| Issuance of common stock | 2,755 | — | 15,171 | — | — | 15,171 |
| Issuance of common stock pursuant to the 2018 ESPP (as defined below) | 282 | — | 1,104 | — | — | 1,104 |
| Other comprehensive loss | — | — | — | (2,555) | — | (2,555) |
| Net Loss | — | — | — | — | (9,900) | (9,900) |
| Balance – June 30, 2023 | 37,088 | $9 | $1,219,530 | $3,043 | $(986,470) | $236,112 |
Three Months Ended June 30, 2023:
| AdditionalPaid-InCapital · AccumulatedOtherComprehensiveIncome · AccumulatedDeficit · Total | ||||||
|---|---|---|---|---|---|---|
| Common Stock | ||||||
| Shares · Amount | ||||||
| Balance – March 31, 2023 | 33,645 | $9 | $1,190,950 | $4,324 | $(962,962) | $232,321 |
| Exercise of common stock options | 4 | — | 11 | — | — | 11 |
| Stock-based compensation | — | — | 12,294 | — | — | 12,294 |
| Settlement of restricted stock | 402 | — | — | — | — | — |
| Issuance of common stock | 2,755 | — | 15,171 | — | — | 15,171 |
| Issuance of common stock pursuant to the 2018 ESPP (as defined below) | 282 | — | 1,104 | — | — | 1,104 |
| Other comprehensive loss | — | — | — | (1,281) | — | (1,281) |
| Net Loss | — | — | — | — | (23,508) | (23,508) |
| Balance – June 30, 2023 | 37,088 | $9 | $1,219,530 | $3,043 | $(986,470) | $236,112 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.